Prof. David Waltregny, Department of Urology, University of Liege-Belgium

David Waltregny is currently professor of clinics and senior staff urologist in the Department of Urology at the University Hospital of Liège, Belgium. He holds membership in several professional and scientific organizations, among which the European Association of Urology, and he is a founding member of the Belgian Association of Urology. After receiving his MD from the University of Liège, David Waltregny became a Senior Research Associate of the Belgian National Fund for Scientific Research, studying the mechanisms of tumor invasion and metastasis, and hormone-independence in human prostate cancer. He then received a PhD from the University of Liège and completed a postdoctoral fellowship at the Dana-Farber Cancer Institute, Harvard Medical School, in Boston. David Waltregny is the author and co-author of numerous publications in top-ranked international journals and is currently pursuing his research works in the Center for Experimental Cancer Research at the University of Liège. David Waltregny largely participated in the development of the TVT-Obturator device together with its inventor, Pr Jean de Leval, at the University of Liège in Belgium. He is pursuing the development of new surgical devices for the treatment of male incontinence that occurs after radical prostatectomy